Unique Ingredient Identifier 94ZLA3W45F is listed as a ingredient substance
| RN | 74-79-3 |
| EC | 200-811-1 |
| NCIT | C62008 |
| RXCUI | 1091 |
| PUBCHEM | 6322 |
| INN ID | 1711 |
| MF | C6H14N4O2 |
| INCHI KEY | ODKSFYDXXFIFQN-BYPYZUCNSA-N |
| SMILES | N[C@@H](CCCNC(N)=N)C(O)=O |
UNII 94ZLA3W45F ARGININE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IM - IV | INJECTION | NA |
| IM - IV | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 78 % |
| INTRAVENOUS | INJECTABLE | 5 % |
| INTRAVENOUS | INJECTION | 39.5 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 78 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 14 % |
| INTRAVENOUS | POWDER, FOR SOLUTION | 70.7 g |
| INTRAVENOUS | SOLUTION, INJECTION | ADJPH |
| INTRAVENOUS INFUSION | INJECTION | 50 mg/1VIAL |
| INTRAVENOUS INFUSION | POWDER | 50 mg/1VIAL |
| IV - SC | INJECTION, SOLUTION | 3.48 MG/1ML |
| IV(INFUSION) | INJECTION | 88 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 8.26 % |
| IV(INFUSION) | SOLUTION, INJECTION | 0.29 % |
| ORAL | TABLET | 25 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 20 MG |
| PARENTERAL | POWDER, FOR INJECTION SOLUTION | NA |